Olaplex (OLPX) – Analysts’ Recent Ratings Changes

Olaplex (NASDAQ: OLPX) has recently received a number of price target changes and ratings updates:

• 3/12/2025 – Olaplex had its “market perform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $2.00 price target on the stock.
• 3/5/2025 – Olaplex had its price target raised by analysts at Barclays PLC from $1.50 to $1.70. They now have an “equal weight” rating on the stock.
• 3/4/2025 – Olaplex had its “market perform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $2.00 price target on the stock.
• 2/25/2025 – Olaplex had its “market perform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $2.00 price target on the stock.

Olaplex Stock Down 0.7 %

OLPX opened at $1.33 on Monday. The business has a 50 day moving average price of $1.51 and a two-hundred day moving average price of $1.86. The company has a quick ratio of 10.32, a current ratio of 11.84 and a debt-to-equity ratio of 0.73. The company has a market cap of $883.94 million, a PE ratio of 22.17 and a beta of 2.44. Olaplex Holdings, Inc. has a 52 week low of $1.19 and a 52 week high of $2.77.

Insider Buying and Selling at Olaplex

In other Olaplex news, insider Trisha L. Fox sold 26,526 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $1.44, for a total transaction of $38,197.44. Following the completion of the sale, the insider now directly owns 461,548 shares of the company’s stock, valued at $664,629.12. This represents a 5.43 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel John C. Duffy sold 35,013 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $1.44, for a total value of $50,418.72. Following the transaction, the general counsel now directly owns 348,630 shares of the company’s stock, valued at approximately $502,027.20. This trade represents a 9.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Olaplex

A number of large investors have recently modified their holdings of the business. Abel Hall LLC raised its stake in shares of Olaplex by 68.1% during the 3rd quarter. Abel Hall LLC now owns 18,261 shares of the company’s stock worth $43,000 after buying an additional 7,397 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Olaplex by 0.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,075,688 shares of the company’s stock worth $1,861,000 after buying an additional 9,661 shares in the last quarter. Belpointe Asset Management LLC raised its stake in shares of Olaplex by 23.6% during the 4th quarter. Belpointe Asset Management LLC now owns 61,461 shares of the company’s stock worth $106,000 after buying an additional 11,724 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Olaplex by 49.1% during the 4th quarter. ProShare Advisors LLC now owns 39,052 shares of the company’s stock worth $68,000 after buying an additional 12,852 shares in the last quarter. Finally, Chemistry Wealth Management LLC purchased a new position in shares of Olaplex during the 4th quarter worth approximately $25,000. 87.37% of the stock is owned by hedge funds and other institutional investors.

Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.